Keyphrases
Urinary Tract Infection
75%
Uropathogenic Escherichia Coli
37%
Recurrent Urinary Tract Infections (rUTIs)
34%
Bladder
33%
Escherichia Coli
31%
Acute Cystitis
23%
Bladder Infection
21%
Uropathogenic E. Coli
21%
Chronic Urinary Tract Infection
20%
Type 1 pili
14%
FimH
13%
Cystitis
11%
Disease Outcome
11%
Urinary Bladder
11%
Mouse Model
10%
Bacterial Infection
10%
Murine Model
10%
Acute Urinary Tract Infection
9%
Inflammation
8%
Vaccine Development
8%
Drug Development
8%
Escherichia Coli Infections
8%
Bacterial Virulence
8%
Antibiotics
8%
Mucosal Immune Response
8%
Urothelial
6%
Alpha-synuclein (α-syn)
6%
Cyclooxygenase-2
6%
Mannoside
6%
Recurrent Infection
6%
Intracellular Bacterial Communities
5%
Synucleinopathy
5%
Multiple System Atrophy
5%
Innate Immune Response
5%
Host-pathogen Interactions
5%
Mucosal Immunity
5%
Bacterial Cystitis
5%
Host Susceptibility
5%
Adhesin
5%
Lower Urinary Tract
5%
Antibiotic Therapy
5%
Bacterial Strains
5%
Immunology and Microbiology
Infection
100%
Urinary Tract
80%
Uropathogenic Escherichia Coli
43%
Escherichia coli
32%
Pilus
11%
Infectious Agent
8%
Innate Immune System
8%
Bacterial Virulence
8%
Susceptibility
6%
Mucosal Immune Response
6%
Immune Response
5%
Host-Pathogen Interaction
5%
Cyclooxygenase
5%
Pharmacology, Toxicology and Pharmaceutical Science
Urinary Tract Infection
56%
Cystitis
26%
Uropathogenic Escherichia Coli
24%
Infection
16%
Escherichia coli
9%
Escherichia Coli Infection
8%
Vaccine Development
8%
Drug Development
8%
Mannoside
8%
Recurrent Disease
7%
Cyclooxygenase 2
7%
Inflammation
6%
Mouse Model
6%